Skip to content

The effect of the gradual change in liquid sodium dialysis hypotension and cramps and blood sodium dialysis patients

The effect of the gradual reduction of liquid sodium dialysis hypotension, muscle cramps and plasma sodium levels in hemodialysis patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2017040833295N1
Enrollment
106
Registered
2017-07-27
Start date
2017-05-22
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

kidney disease. Unspecified kidney failure

Interventions

Intervention 1: Patients in the control group treated with routine method (sodium dialysis solution 138 meq per liter in total duration of dialysis) for three sessions of dialysis and then both interv
Prevention
Patients in the control group treated with routine method (sodium dialysis solution 138 meq per liter in total duration of dialysis) for three sessions of dialysis and then both intervention and contr
Intervention group patients on hemodialysis with the gradual reduction of sodium dialysis solution (starting with 150 meq per liter and cut it every 15 minutes, and then maintain this concentration) f

Sponsors

Shahrood University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria include patients with end-stage renal failure (ESRD); patients aged between 75 and 18, who have been undergoing hemodialysis 2-3 times a week for at least two months; and patients who are willing to participate in the plan. Exclusion criteria include patients who use anti-cramp medication; patients who are not under the control of their physician's blood pressure department; use of medications to lower blood pressure in the morning before dialysis; heart disease, such as heart attack, over a period of six months Recent; patients with discharge fraction of less than 30%; the presence of pacemakers in patients.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Blood pressure. Timepoint: Before dialysis, first, second and third and fourth hours of dialysis, the dialysis. Method of measurement: -Br millimeters of mercury using mercury manometer.;Muscle cramps. Timepoint: Before dialysis, during dialysis, the dialysis. Method of measurement: questionnaire.;Plasma sodium. Timepoint: Before dialysis, the dialysis. Method of measurement: In terms of mEq per liter by laboratories.

Secondary

MeasureTime frame
Hypotension during dialysis. Timepoint: Before dialysis, during dialysis, the dialysis. Method of measurement: -Br millimeters of mercury using mercury manometer.;Magnesium is the blood. Timepoint: Pre-dialysis and dialysis later. Method of measurement: Mg / dl.;Calcium of the blood. Timepoint: Pre-dialysis and dialysis later. Method of measurement: Mg / dl.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactUosra Majidi

Shahrood University of Medical Sciences

uosra1365.majidi@gmail.com+98 23 31420

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026